MoonLake Immunotherapeutics
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phas…
Biotechnology
CH, Zug [HQ]
Balance Sheet
4 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Assets | 116.00 | 9.00 | 76.00 | 526.00 | |
|
Current
|
1.00 | 9.00 | 76.00 | 514.00 | |
| Cash And Equivalents | 1.00 | 8.00 | 39.00 | 451.00 | |
| Assets | 116.00 | 9.00 | 76.00 | 526.00 | |
| Accounts Receivables (AR) | - - | - - | - - | - - | |
| Inventory | - - | 1.00 | - - | - - | |
| Short Term Investments | - - | - - | 32.00 | 59.00 | |
| Other Current Assets | - - | - - | 4.00 | 2.00 | |
|
Non Current
|
115.00 | - - | - - | 12.00 | |
| Property, Plant, Equipment (Net) | - - | - - | - - | 3.00 | |
|
Intangible Assets
|
- - | - - | - - | - - | |
| Goodwill | - - | - - | - - | - - | |
| Long Term Investments | 115.00 | 115.00 | - - | - - | |
| Other Non Current Assets | - - | -115.00 | - - | 8.00 | |
| Liabilities | 4.00 | 21.00 | 8.00 | 13.00 | |
|
Current
|
- - | 21.00 | 7.00 | 9.00 | |
| Accounts Payable | - - | 1.00 | -1.00 | - - | |
| Short Term Debt | - - | 15.00 | - - | 1.00 | |
| Deferred Revenue | - - | - - | - - | - - | |
| Tax Payable | - - | - - | - - | - - | |
| Other Current Liabilities | - - | 4.00 | 7.00 | 8.00 | |
|
Non Current
|
4.00 | - - | - - | 3.00 | |
| Long Term Debt | - - | - - | - - | 2.00 | |
| Leasing Obligations | - - | - - | - - | 2.00 | |
| Deferred Non Current Tax Liabilities | - - | - - | - - | - - | |
| Other Non Current Liabilities | 4.00 | - - | - - | - - | |
| Equity | 112.00 | -11.00 | 68.00 | 513.00 | |
| Stockholders' Equity | 112.00 | -11.00 | 48.00 | 495.00 | |
| Retained Earnings | -2.00 | -53.00 | -80.00 | -116.00 | |
| Common Stock | 115.00 | - - | - - | - - | |
| Preferred Stock | - - | - - | - - | - - | |
| Profit | - - | -53.00 | -64.00 | -36.00 | |
| Dividends | - - | - - | - - | - - | |
| Minority Interest | - - | - - | 19.00 | 17.00 | |
| Other Stockholders' Equity | - - | 42.00 | 129.00 | 609.00 | |
| Loss Other Compr. Income | - - | - - | - - | 2.00 |